Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 691 AL 705

Overview on wearable sensors for the management of Parkinson's disease

Moreau C, Rouaud T, Grabli D, Benatru I, Remy P, Marques AR, Drapier S, Mariani LL, Roze E, Devos D, Dupont G, Bereau M, Fabbri M.

NPJ Parkinsons Dis. 2023 Nov 2;9(1):153. doi: 10.1038/s41531-023-00585-y.

Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease

Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR.

Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023.

Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

Price S, Ruppar TM.

Appl Nurs Res. 2023 Dec;74:151745. doi: 10.1016/j.apnr.2023.151745. Epub 2023 Oct 28.

T-type calcium channels as therapeutic targets in essential tremor and Parkinson's disease

Matthews LG, Puryear CB, Correia SS, Srinivasan S, Belfort GM, Pan MK, Kuo SH.

Ann Clin Transl Neurol. 2023 Apr;10(4):462-483. doi: 10.1002/acn3.51735. Epub 2023 Feb 4.

Transcranial low-intensity ultrasound stimulation for treating central nervous system disorders: A promising therapeutic application

Hu YY, Yang G, Liang XS, Ding XS, Xu DE, Li Z, Ma QH, Chen R, Sun YY.

Front Neurol. 2023 Mar 8;14:1117188. doi: 10.3389/fneur.2023.1117188. eCollection 2023.

The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson's Disease in Zebrafish: The Current Applications and Perspectives

Abidar S, Hritcu L, Nhiri M.

CNS Neurol Disord Drug Targets. 2023;22(10):1472-1483. doi: 10.2174/1871527322666221028152600.

Shoulder Dysfunction in Parkinson Disease: Review of Clinical, Imaging Findings and Contributing Factors

Paggou D, Stefanis L, Chronopoulos E, Ghika A, Kyrozis A, Balanika A, Baltas C, Potagas C.

J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):263-280.

An Apple a Day to Keep the Parkinson's Disease Doctor Away?

Bloem BR, Post E, Hall DA.

Ann Neurol. 2023 Apr;93(4):681-685. doi: 10.1002/ana.26612. Epub 2023 Feb 9.

Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy

Paccosi E, Proietti-De-Santis L.

Int J Mol Sci. 2023 May 31;24(11):9547. doi: 10.3390/ijms24119547.

Longitudinal brain functional connectivity changes induced by neurosurgical thalamotomy for tremor in Parkinson's disease: a preliminary study

Albano L, Basaia S, Emedoli D, Balestrino R, Pompeo E, Barzaghi LR, Castellano A, Falini A, Iannaccone S, Mortini P, Filippi M, Agosta F.

J Neurol. 2023 Jul;270(7):3623-3629. doi: 10.1007/s00415-023-11705-2. Epub 2023 Apr 15.

Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease

Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, Thompson JA.

J Neurophysiol. 2023 Jun 1;129(6):1492-1504. doi: 10.1152/jn.00055.2023. Epub 2023 May 17.

Vitamin D and neurodegenerative diseases

Wang W, Li Y, Meng X.

Heliyon. 2023 Jan 12;9(1):e12877. doi: 10.1016/j.heliyon.2023.e12877. eCollection 2023 Jan.

Pharmacological Treatment of Tremor in Parkinson's Disease Revisited

Pirker W, Katzenschlager R, Hallett M, Poewe W.

J Parkinsons Dis. 2023;13(2):127-144. doi: 10.3233/JPD-225060.

Identification and Management of Persistent Stimulation-Induced Dyskinesia Associated with STN DBS: The See-Saw Dilemma

Remz MA, Wong JK, Hilliard JD, Tholanikunnel T, Rawls AE, Okun MS.

Tremor Other Hyperkinet Mov (N Y). 2023 Aug 28;13:28. doi: 10.5334/tohm.780. eCollection 2023.

SIGMAR1 variants in ALS-PD complex cases: a case report of a novel mutation and literature review

Li H, Xuan T, Xu T, Yang J, Cheng J, Wang Z.

Front Neurol. 2023 Sep 13;14:1242472. doi: 10.3389/fneur.2023.1242472. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias